MD Medical Group opens new clinic in Moscow
|Download file (365 K)|
MD Medical Group Investments Plc (“MD Medical Group”, “MDMG” or the “Company” – LSE: MDMG), a leading Russian private healthcare provider, announces that it has opened a new clinic in Moscow. The Group’s total investment in the project amounted to approx. 57 million roubles.
The new clinic Mother&Child Lefortovo has an area of 392 sq. m. It offers both the Group’s core services such as OBGYN, IVF and ultrasound, and medical services for a wider range of patients, including in genetics, cardiology, urology, and endocrinology.
The new clinic is capable of carrying out up to 1,000 IVF cycles and more than 20,000 out-patient treatments per year.
Mark Kurtser, CEO of MD Medical Group, said:
“Moscow is the biggest and growing healthcare market in the country and it is important for us to continue expanding our presence in Russia’s capital. Moscow is a large city, it is important to make our services accessible for residents of different neighbourhoods. Thus, our new clinic in Lefortovo will focus on serving patients from the large residential areas in the east of Moscow.“The clinic will maintain our Company’s traditional focus on women’s healthcare, however it also will offer other medical services. I am confident that the new clinic will quickly gain popularity among patients.”
For further information please contact:
MD Medical Group Investments Plc
Tel: +7 495 331 4120
Tom Blackwell: +7 919 102 9064
Sergii Pershyn: +1 929 855 8188
About MD Medical Group
MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 37 modern healthcare facilities, including 5 hospitals and 32 outpatient clinics in Moscow and the Moscow Region, St. Petersburg, Ufa, Perm, Samara and the Samara Region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, Vladimir, Tyumen, Voronezh, and Nizhny Novgorod.
The Company’s shares have been listed on the London Stock Exchange (LSE ticker “MDMG”) in the form of Global Depositary Receipts (GDRs) since 12 October 2012.
This press release contains forward looking statements, which are based on the Company’s current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company’s ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.
No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.
2019 2018 2017 2016 2015 2014 2013 2012